OpenEye, Cadence Molecular Sciences
Adam Green has a diverse work experience in the field of science and research. Adam most recently worked as an Application Scientist at OpenEye, Cadence Molecular Sciences since July 2021. Prior to that, from October 2019 to July 2021, they held the position of Field Application Scientist at BIOVIA. In this role, they promoted and demonstrated BIOVIA's collaborative science solutions to potential customers, provided support to existing customers, and collaborated with the R&D team to improve software solutions.
Before their time at BIOVIA, Green worked as a Graduate Research Assistant at Oak Ridge National Laboratory from August 2016 to October 2019. Adam also gained teaching experience as a Graduate Teaching Assistant at the University of Tennessee from August 2014 to August 2016. Prior to their graduate studies, Green worked as an Undergraduate Research Assistant at Wake Forest University from January 2013 to July 2014. Adam also served as an Administrative Assistant at Wake Forest University's Office of Research and Sponsored Programs from August 2010 to May 2011.
Adam Green completed their Bachelor of Science (BS) degree in Biology and Chemistry at Wake Forest University from 2010 to 2014. Adam then pursued a Doctor of Philosophy (Ph.D.) in Life Sciences with a specialization in Computational Molecular Biophysics at the University of Tennessee, Knoxville from 2014 to 2019. Additionally, in November 2017, they obtained a certification in Neural Networks and Deep Learning from Coursera.
This person is not in any offices
OpenEye, Cadence Molecular Sciences
1 followers
OpenEye Scientific is an industry leader in computational molecular design based on decades of delivering rapid, robust, and scalable software, toolkits, and technology and design services across the drug discovery process. Our scientific approach has focused on visualizing and analyzing the shape and electrostatics of molecular 3D structures to inform and guide the advancement of pharmaceuticals and biotechnology. OpenEye recently integrated its applications and toolkits into Orion, the only cloud-native, fully integrated molecular design platform. Combining unlimited computation and storage with powerful tools for data sharing, visualization and analysis in an open development platform, Orion offers unprecedented capabilities for drug discovery and optimization. Founded in 1997, OpenEye is a privately held company headquartered in Santa Fe, New Mexico, with offices in Boston, Massachusetts; Cologne, Germany; and Tokyo, Japan. For more information, go to http://www.eyesopen.com.
Employees
51-200